Basit öğe kaydını göster

The Impact of Visible Tumor (PI-RADS >= 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis

dc.contributor.authorSaglican, Yesim
dc.contributor.authorBalbay, Mevlana Derya
dc.contributor.authorCanda, Abdullah Erdem
dc.contributor.authorKordan, Yakup
dc.contributor.authorKiremit, Murat Can
dc.contributor.authorCil, Barbaros
dc.contributor.authorTugcu, Volkan
dc.contributor.authorBakir, Baris
dc.contributor.authorEsen, Tarik
dc.contributor.authorOzkan, Arif
dc.contributor.authorKoseoglu, Ersin
dc.contributor.authorKilic, Mert
dc.contributor.authorBaydar, Dilek Ertoy
dc.date.accessioned2022-07-04T14:46:55Z
dc.date.available2022-07-04T14:46:55Z
dc.date.issued2022
dc.identifier.citationOzkan A., Koseoglu E., Kilic M., Baydar D. E. , Saglican Y., Balbay M. D. , Canda A. E. , Kordan Y., Kiremit M. C. , Cil B., et al., "The Impact of Visible Tumor (PI-RADS >= 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis", CLINICAL GENITOURINARY CANCER, cilt.20, sa.1, 2022
dc.identifier.issn1558-7673
dc.identifier.othervv_1032021
dc.identifier.otherav_8d7a9561-6ed0-4193-87a6-f9c49dcdf20c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/183683
dc.identifier.urihttps://doi.org/10.1016/j.clgc.2021.09.007
dc.description.abstractDeciding on the management of prostate cancer (PCa), especially GG1 PCa, is quite difficult. The most important thing that will help us in making active surveillance or definitive treatment decision is whether the tumor is a clinically significant tumor. To understand this, we discussed in this article that multiparametric MR, PI-RADS scoring and targeted biopsy can be used.
dc.language.isoeng
dc.subjectNephrology
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectUrology
dc.subjectHealth Sciences
dc.titleThe Impact of Visible Tumor (PI-RADS >= 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis
dc.typeMakale
dc.relation.journalCLINICAL GENITOURINARY CANCER
dc.contributor.departmentKoc Univ Hosp Istanbul , ,
dc.identifier.volume20
dc.identifier.issue1
dc.contributor.firstauthorID3422098


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster